GLP-1 agonist Liraglutide prevents MK‑801-induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice.
GLP-1激動劑 Liraglutide 預防 MK-801誘導的類精神分裂症行為,並調節Balb/c小鼠海馬和前額葉皮質中的BDNF、CREB、p-CREB、Trk-B表達。
Behav Brain Res 2023-04-05
Exendin-4 protects against high glucose-induced mitochondrial dysfunction and oxidative stress in SH-SY5Y neuroblastoma cells through GLP-1 receptor/Epac/Akt signaling.
Exendin-4透過GLP-1受體/Epac/Akt信號傳遞,在SH-SY5Y神經母細胞中保護免受高葡萄糖誘導的線粒體功能障礙和氧化壓力。
Eur J Pharmacol 2023-07-24
Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus.
糖尿病認知衰退和失智症治療中胰高血糖素樣肽-1受體激動劑的潛在作用。
Int J Mol Sci 2023-08-07
GLP-1 plays a protective role in hippocampal neuronal cells by activating cAMP-CREB-BDNF signaling pathway against CORT+HG-induced toxicity.
GLP-1透過激活cAMP-CREB-BDNF信號通路,在CORT+HG誘導的毒性作用下,對海馬神經細胞發揮保護作用。
Heliyon 2023-08-15
Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer's disease models: a systematic review and meta-analysis of preclinical studies.
GLP-1受體激動劑在實驗性阿茲海默症模型中的應用:對預臨床研究的系統性回顧和荟萃分析。
Front Pharmacol 2023-10-03
Daphnetin modulates GLP-1R to alleviate cognitive dysfunction in diabetes: implications for inflammation and oxidative stress.
Daphnetin 調節 GLP-1R 以減輕糖尿病中的認知功能障礙:對炎症和氧化壓力的啟示。
Front Pharmacol 2024-09-11